Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial

Clinical trial NCT02330406 · COMPLETED

Trial details

NCT number: NCT02330406
Sponsor: Institute for Clinical Effectiveness, Japan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dipeptidyl-Peptidase 4 Inhibitors LDL Cholesterol Glycosylated Hemoglobin Diabetes Mellitus Coronary Disease

Start date: 2015-04-01
Primary completion: 2018-01-01
Enrollment: 353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.